Alto Neuroscience, Inc. 8-K

What Happened

• Alto Neuroscience, Inc. (ANRO) filed a Current Report on Form 8-K on July 13, 2026 reporting information under Item 2.02 (Results of Operations and Financial Condition) that discloses its "Cash, Cash Equivalents and Restricted Cash as of June 30, 2026."
• The company also stated under Item 8.01 (Other Events) that this cash position disclosure is incorporated by reference into the Form 8‑K but is being furnished (not “filed”) and therefore is not subject to the liability protections of Section 18 of the Exchange Act.

Key Details

• Filing date: July 13, 2026 (Current Report on Form 8‑K).
• Disclosure topic: cash, cash equivalents and restricted cash as of June 30, 2026 (specific dollar amounts are included in the company filing).
• Legal treatment: the cash-position disclosure is furnished, not filed, and thus not subject to Section 18 liabilities or automatic incorporation by reference in future securities filings except where expressly stated.

Why It Matters

• Cash, cash equivalents and restricted cash give investors a snapshot of Alto’s liquidity and short-term runway; investors should review the filing for the specific dollar amounts and context.
• The company’s designation of the disclosure as “furnished” (rather than “filed”) limits certain legal liabilities and affects how the information may be used in future SEC filings.
• For a complete view of Alto’s quarterly results and financial condition, investors should read the full 8‑K and any accompanying financial statements or MD&A where the company provides amounts and context for its cash position.